Multiple Sclerosis Clinical Trial
Official title:
Body-weight Supported Treadmill Training in Primary Progressive Multiple Sclerosis: A Pilot Trial
This study is a pilot trial to evaluate the effects of supported treadmill walking in
patients with primary progressive multiple sclerosis (MS) on functional and psychosocial
outcomes. Patients will exercise three times per week over the course of 6 months and will
be evaluated at baseline, 12 weeks and 24 weeks into the program. Follow-up testing will
also be conducted 12 weeks after participants have stopped exercising to determined the
lasting effects of the intervention.
The investigators hypothesize that supported treadmill walking will be effective at
improving physical physical function and psychosocial outcomes in patients with primary
progressive MS.
The use of exercise as an adjunct to other disease modifying treatments in MS has found
increasing support over the past decade. There is ample evidence that exercise therapy can
improve physical measures of disability in MS, in addition to being safe and well-tolerated.
However, there is a paucity of data on whether exercise is equally effective for those with
primary progressive MS as it is in relapsing remitting MS. In addition, studies of exercise
therapy have traditionally excluded MS patients with severe disability. There are also
currently no treatments for primary progressive MS, so finding a safe disease-modifying
therapy is of the utmost importance. The investigators are therefore conducting a pilot
trial to evaluate the effects of exercise in the form of supported treadmill walking for
patients with primary progressive MS with severe functional impairments.
Six patients with primary progressive MS with high disability level will be recruited to
participate in this study. Participants will exercise using body-weight supported treadmill
training (BWSTT; Woodway Loco-system) which allows a portion of an individual's body-weight
to be counterbalanced by an overhead pulley system. This system allows patients with limited
mobility to walk upright on the treadmill with therapist assistance. Therapists trained in
using the BWSTT system will guide the patients' legs through a proper gait motion and assist
with lower limb control. Participants will complete 72 training sessions (30min/session,
3x/week) over the course of 24 weeks. Participants will be evaluated at baseline, 12 weeks
(half-way through the training program) and 24 weeks (end of intervention). A follow-up
assessment will also be performed 12 after participants have completed the training program
(36 weeks). Outcome measures are described below.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|